Drug Type Nanobody |
Synonyms |
Target |
Mechanism IL-4Rα inhibitors(Interleukin-4 receptor subunit alpha inhibitors), TSLP inhibitors(Thymic stromal lymphopoietin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | CN | - | |
Dermatitis, Atopic | Preclinical | CN | - | |
Rhinitis | Preclinical | CN | - |